-
Autor
Akbarov, Artur 1 Cole, Richard 1 Gulsin, Gaurav S 1 Gupta, Pankaj 1 Holaj, Robert 1 Kinnell, Angela 1 Lai, Florence Y 1 Marešová, Věra 1 Patel, Prashanth 1 Patel, Veena 1 Petrák, Ondřej 1 Rosa, Ján 1 Samani, Nilesh J 1 Smith, Paul R 1 Squire, Iain 1 Thompson, John R 1 Tomaszewski, Maciej 1 White, Christobelle M J 1 Widimský, Jiří 1 Williams, Bryan 1
-
Pracoviště
3rd Department of Medicine Department of End... 1 Department of Cardiovascular Sciences Britis... 1 Derby Teaching Hospitals NHS Foundation Trus... 1 Division of Cardiovascular Sciences Faculty ... 1 Division of Medicine Central Manchester NHS ... 1 From the Department of Metabolic Medicine an... 1 Institute of Cardiovascular Science Universi... 1 National Institute for Health Research Unive... 1 National Institute of Health Research Leices... 1 University Hospitals of Leicester NHS Trust ... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Zeměpisné označení
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Gupta, Pankaj
Autor Gupta, Pankaj From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Patel, Prashanth
Autor Patel, Prashanth From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Štrauch, Branislav
Autor Štrauch, Branislav From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Lai, Florence Y
Autor Lai, Florence Y From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Akbarov, Artur
Autor Akbarov, Artur From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Marešová, Věra
Autor Marešová, Věra From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
White, Christobelle M J
Autor White, Christobelle M J From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Petrák, Ondřej
Autor Petrák, Ondřej From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Gulsin, Gaurav S
Autor Gulsin, Gaurav S From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
-
Patel, Veena
Autor Patel, Veena From the Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, United Kingdom (P.G., P.P., R.C., A.K., P.R.S.) National Institute of Health Research, Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, United Kingdom (P.G., P.P., F.Y.L., G.S.G., I.S., N.J.S.) Department of Cardiovascular Sciences, British Heart Foundation Cardiovascular Research Centre (P.G., P.P., F.Y.L., C.M.J.W., G.S.G., I.S., N.J.S.) and Department of Health Sciences (J.R.T.), University of Leicester, United Kingdom Third Department of Medicine, Department of Endocrinology and Metabolism, Hypertension Centre, General University Hospital (B.S., O.P., J.R., T.Z., R.H., J.W.), Institute of Forensic Medicine and Toxicology, General University Hospital (V.M.), and Cardiocentre, University Hospital Královské Vinohrady (J.R.), Charles University, Prague, Czech Republic Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.A., M.T.) University Hospitals of Leicester NHS Trust, United Kingdom (G.S.G.) Derby Teaching Hospitals NHS Foundation Trust, United Kingdom (V.P.) Institute of Cardiovascular Science, University College London, United Kingdom (B.W.) National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, United Kingdom (B.W.) and Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom (M.T.)
NLK
Free Medical Journals
od 1979 do Před 1 rokem
Open Access Digital Library
od 1979-01-01
Open Access Digital Library
od 1979-01-01
PubMed
28461599
DOI
10.1161/hypertensionaha.116.08729
Knihovny.cz E-zdroje
Nonadherence to antihypertensive treatment is a critical contributor to suboptimal blood pressure control. There are limited and heterogeneous data on the risk factors for nonadherence because few studies used objective-direct diagnostic methods. We used high-performance liquid chromatography-tandem mass spectrometry of urine and serum to detect nonadherence and explored its association with the main demographic- and therapy-related factors in 1348 patients with hypertension from 2 European countries. The rates of nonadherence to antihypertensive treatment were 41.6% and 31.5% in the UK and Czech populations, respectively. Nonadherence was inversely related to age and male sex. Each increase in the number of antihypertensive medications led to 85% and 77% increase in nonadherence (P<0.001) in the UK and Czech populations, respectively. The odds of nonadherence to diuretics were the highest among 5 classes of antihypertensive medications (P≤0.005 in both populations). The predictive model for nonadherence, including age, sex, diuretics, and the number of prescribed antihypertensives, showed area under the curves of 0.758 and 0.710 in the UK and Czech populations, respectively. The area under the curves for the UK model tested on the Czech data and for the Czech model tested on UK data were calculated at 0.708 and 0.756, respectively. We demonstrate that the number and class of prescribed antihypertensives are modifiable risk factors for biochemically confirmed nonadherence to blood pressure-lowering therapy. Further development of discriminatory models incorporating these parameters might prove clinically useful in assessment of nonadherence in countries where biochemical analysis is unavailable.
- MeSH
- adherence k farmakoterapii statistika a číselné údaje MeSH
- adherence pacienta statistika a číselné údaje MeSH
- antihypertenziva terapeutické užití MeSH
- diuretika terapeutické užití MeSH
- hodnocení rizik MeSH
- hypertenze diagnóza farmakoterapie MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- měření krevního tlaku metody MeSH
- prediktivní hodnota testů MeSH
- retrospektivní studie MeSH
- senioři MeSH
- sexuální faktory MeSH
- stupeň závažnosti nemoci MeSH
- věkové faktory MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- Geografické názvy
- Česká republika MeSH
- Spojené království MeSH
Upřesnit dle MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.